Get the Stockscreener App
220.52
0.28%
0.61
After Hours:
220.52
Iqvia Holdings Inc stock is traded at $220.52, with a volume of 1.29M.
It is up +0.28% in the last 24 hours and up +21.67% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$219.91
Open:
$220.01
24h Volume:
1.29M
Relative Volume:
0.89
Market Cap:
$37.49B
Revenue:
$15.70B
Net Income/Loss:
$1.24B
P/E Ratio:
31.94
EPS:
6.9036
Net Cash Flow:
$2.01B
1W Performance:
+7.81%
1M Performance:
+21.67%
6M Performance:
+46.35%
1Y Performance:
+4.16%
1-Day Range:
$219.92
$221.97
1-Week Range:
$205.01
$225.00
52-Week Range:
$134.65
$225.91
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
220.52 | 37.38B | 15.70B | 1.24B | 2.01B | 6.9036 |
|
TMO
Thermo Fisher Scientific Inc
|
572.50 | 215.96B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
223.01 | 157.33B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
640.85 | 51.09B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
148.03 | 41.80B | 6.79B | 1.22B | 1.09B | 4.2644 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
Using AI based signals to follow IQVIA Holdings Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
IQVIA Holdings Inc. stock prediction for this weekPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Why IQVIA Holdings Inc. (QTS) stock benefits from AI revolutionMarket Performance Report & Real-Time Buy Zone Alerts - newser.com
Why IQVIA Holdings Inc. stock stays undervaluedTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Will IQVIA Holdings Inc. (QTS) stock split increase liquidityJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
Should you wait for a breakout in IQVIA Holdings Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Will IQVIA Holdings Inc. stock outperform international peers2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
IQVIA Holdings Inc. stock momentum explainedPortfolio Return Summary & Fast Gain Stock Trading Tips - newser.com
Is IQVIA Holdings Inc. stock attractive for passive investorsMarket Volume Report & Stock Timing and Entry Methods - newser.com
How IQVIA Holdings Inc. stock performs in rate cut cyclesWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Will IQVIA Holdings Inc. stock deliver strong dividend growth2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Why IQVIA Holdings Inc. stock could break out in 2025Earnings Recap Report & Verified Chart Pattern Signals - newser.com
IQVIA to raise $2B via senior notes offering to repay debt - MSN
IQVIA Gears Up to Report Q3 Earnings: What's in the Cards? - sharewise.com
IQVIA Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Will IQVIA Holdings Inc. stock rally after Fed decisionsRisk Management & Consistent Income Trade Recommendations - newser.com
How IQVIA Holdings Inc. (QTS) stock reacts to fiscal policiesIPO Watch & Stepwise Entry and Exit Trade Signals - newser.com
What Catalysts Could Shift the Narrative for IQVIA Amid New Analyst Insights and Partnerships - Yahoo Finance
Is IQVIA Holdings Inc. stock a top pick for value investorsWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com
IQVIA Holdings Inc (IQV)'s Winning Formula: Financial Metrics an - GuruFocus
Will IQVIA Holdings Inc. stock benefit from infrastructure billJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com
Exit strategy if you’re trapped in IQVIA Holdings Inc.July 2025 Trends & Fast Gaining Stock Strategy Reports - newser.com
IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025 - BioSpace
Why IQVIA Holdings Inc. (QTS) stock remains stableWeekly Investment Summary & Stock Timing and Entry Methods - newser.com
Relative strength of IQVIA Holdings Inc. in sector analysisRate Cut & Fast Gain Swing Trade Alerts - newser.com
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? - sharewise.com
What recovery options are there for IQVIA Holdings Inc.July 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
Is IQVIA Holdings Inc. stock a safe haven asset2025 Dividend Review & Weekly Top Gainers Alerts - newser.com
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):